Target intelligence / Profile preview

Ribosomal protein L7 pseudogene 17 (RPL7P17)

Target
RPL7P17
Molecular classification
Other (pseudogene)
01

Overview

Ribosomal protein L7 pseudogene 17 (RPL7P17) is a pseudogene of the RPL7 gene, not a protein-coding or functional gene product[5][8]. It does not encode a functional protein or receptor and is not considered a therapeutic target. The parent gene, RPL7, encodes a component of the 60S large ribosomal subunit involved in protein synthesis, but RPL7P17 itself is a non-functional, processed pseudogene that arose from genomic duplication events and does not have known biological or pathological function[4][8][5]. Key clarifications: - RPL7P17 is not a protein, receptor, enzyme, or any other direct molecular target category; it is a pseudogene[5][8]. - There is no evidence in the literature or validated databases that this pseudogene is expressed or translated into a functional product, nor is it implicated in disease biology or targeted by any drugs[5][8]. - The entry is "incorrect" or not targetable if you require a bona fide protein, receptor, or gene product. If your inquiry was instead about the parent gene, use "60S ribosomal protein L7" (RPL7)[1][4]. For the pseudogene RPL7P17, only basic nomenclature and its classification as a pseudogene are accurate.

Other names
RPL7_6_493RPL7P17

Beyond the preview

Go deeper on Ribosomal protein L7 pseudogene 17 (RPL7P17).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7 pseudogene 17 (RPL7P17).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call